Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
246 LiteraturKapitel 131. Chalmers 1, Glasziou P. Avoidable waste in the production and reporting of researchevidence. Lancet 2009; 374: 86–89.2. Roberts I, Yates D, San<strong>der</strong>cock P, et al; CRASH trial collaborators. Effect of intravenouscorticosteroids on death within 14 days in 10008 adults with clinicallysignificant head injury (MRC CRASH trial): randomised placebo-controlledtrial. Lancet 2004; 364: 1321–1328.3. Cochrane Injuries Group Albumin Reviewers. Human albumin admin<strong>ist</strong>rationin critically ill patients: systematic review of randomised controlled trials. BMJ1998; 317: 235–240.4. Finfer S, Bellomo R, Bryce N, et al (SAFE Study Investigators). A comparison ofalbumin and saline for fluid resuscitation in the intensive care unit. New EnglandJournal of Medicine 2004; 350: 2247–2256.5. Edwards A, Elwyn G, Atwell C, et al. Shared decision making and risk communicationin general practice – a study incorporating systematic literature reviews,psychometric evaluation of outcome measures, and quantitative, qualitative andhealth economic analyses of a cluster randomised trial of professional skill development.Report to Health in Partnership programme, UK Department ofHealth. Cardiff: Department of General Practice. University of Wales College ofMedicine, 2002.6. Farrell C, ed. Patient and public involvement in health: The evidence for policyimplementation. A summary of the results of the Health in Partnership researchprogramme. London: Department of Health Publications, April 2004. Zugänglichunter: www.dh.gov.uk/en/Publicationsandstat<strong>ist</strong>ics/Publications/Publications-PolicyAndGuidance/DH_4082332.7. Donovan J, Mills N, Smith M, et al for the ProtecT Study Group. Quality improvementreport: improving design and conduct of randomised trials by embeddingthem in qualitative research: ProtecT (prostate testing for cancer andtreatment) study. BMJ 2002; 325: 766–770.8. Dickersin K, Chalmers I. Recognising, investigating and dealing with incompleteand biased reporting of clinical research: from Francis Bacon to the <strong>Wo</strong>rldHealth Organization. James Lind Library, 2010 (www. jameslindlibrary.org).9. Chan A-W, Hróbjartsson A, Haahr MT, et al. Empirical evidence for selectivereporting of outcomes in randomized trials: comparison of protocols to publishedarticles. JAMA 2004; 291: 2457–2465.10. Chan AW, Altman DG. Epidemiology and reporting of randomised trials publishedin PubMed journals. Lancet 2005; 365: 1159–1162.11. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptionsof treatment in trials and reviews? BMJ 2008; 336: 1472–1474.12. Clarke M, Hopewell S, Chalmers I. Clinical trials should begin and end withsystematic reviews of relevant evidence: 12 years and waiting. Lancet 2010; 376:20–21.© 2013 by Verlag Hans Huber, Hogrefe AG, BernDieses Dokument <strong>ist</strong> nur <strong>für</strong> den persönlichen Gebrauch bestimmt und darf in k<strong>eine</strong>r Form vervielfältigt und an Dritte weitergegeben werden.Aus: Imogen Evans, Hazel Thornton, Iain Chalmers, Paul Glasziou; <strong>Wo</strong> <strong>ist</strong> <strong>der</strong> <strong>Beweis</strong>? – <strong>Plädoyer</strong> <strong>für</strong> <strong>eine</strong> <strong>evidenzbasierte</strong> <strong>Medizin</strong>. 1. Auflage.
Change language